- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 144-158 of
397 results
1036 Exhibit: Orange Book Approved Drug Products with Therapeutic Equivalence...
Document
IPR2018-00943, No. 1036-31 Exhibit - Orange Book Approved Drug Products with Therapeutic Equivalence Evaluations (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1005 Exhibit: US Serial Number 11083,167, Office Action, Jan 6, 2010
Document
IPR2018-00943, No. 1005-5 Exhibit - US Serial Number 11083,167, Office Action, Jan 6, 2010 (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1002 Exhibit: US Serial Number 11083,167, Office Action, May 5, 2009
Document
IPR2018-00943, No. 1002-2 Exhibit - US Serial Number 11083,167, Office Action, May 5, 2009 (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1049 Exhibit: Rothenberg et al, Behavioral naltrexone therapy an integrated treatm...
Document
IPR2018-00943, No. 1049-44 Exhibit - Rothenberg et al, Behavioral naltrexone therapy an integrated treatment for opiate dependence (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1003 Exhibit: Serial No 11083,167, Declaration Under 37 CFR 1132 of Elliot Ehrich ...
Document
IPR2018-00943, No. 1003-3 Exhibit - Serial No 11083,167, Declaration Under 37 CFR 1132 of Elliot Ehrich undated (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1038 Exhibit: Synopsis, Naltrexone HC1, ALZA Corporation
Document
IPR2018-00943, No. 1038-33 Exhibit - Synopsis, Naltrexone HC1, ALZA Corporation (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1044 Exhibit: Bertil Abrahamsson and Anna Lena Ungell, Biopharmaceutical suppo...
Document
IPR2018-00943, No. 1044-39 Exhibit - Bertil Abrahamsson and Anna Lena Ungell, Biopharmaceutical support in formulation development (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1011 Exhibit: Henry R Kranzler et al, Sustained Release Naltrexone for Alcoholism ...
Document
IPR2018-00943, No. 1011-58 Exhibit - Henry R Kranzler et al, Sustained Release Naltrexone for Alcoholism Treatment A Preliminary Study (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1059 Exhibit: WayBack Machine capture of Security and Exchange Commissions In...
Document
IPR2018-00943, No. 1059-61 Exhibit - WayBack Machine capture of Security and Exchange Commissions Information Page regarding the Electronic Data Gathering, Analysis, and Retrieval Sys...
|
|
Cite Document
1014 Exhibit: US Patent No 7,157,102
Document
IPR2018-00943, No. 1014-14 Exhibit - US Patent No 7,157,102 (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1023 Exhibit: ReVia, Physicians Desk Reference 936 938 53rd ed 1999
Document
IPR2018-00943, No. 1023-21 Exhibit - ReVia, Physicians Desk Reference 936 938 53rd ed 1999 (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1028 Exhibit: Rubio, et al, Naltrexone versus acamprosate one year follow up of alc...
Document
IPR2018-00943, No. 1028-59 Exhibit - Rubio, et al, Naltrexone versus acamprosate one year follow up of alcohol dependence treatment (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1040 Exhibit: TREXAN, Physicians Desk Reference 936 938 46 ed 1992
Document
IPR2018-00943, No. 1040-35 Exhibit - TREXAN, Physicians Desk Reference 936 938 46 ed 1992 (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1019 Exhibit: SJ Heishman et al, Safety And Pharmacokinetics of a New Formulatio...
Document
IPR2018-00943, No. 1019-17 Exhibit - SJ Heishman et al, Safety And Pharmacokinetics of a New Formulation of Depot Naltrexone (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1027 Exhibit: Appeal Brief, Application No 13871,534, Oct 19, 2015
Document
IPR2018-00943, No. 1027-25 Exhibit - Appeal Brief, Application No 13871,534, Oct 19, 2015 (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
